Literature DB >> 22320238

Double heterozygous mutations of MITF and PAX3 result in Waardenburg syndrome with increased penetrance in pigmentary defects.

T Yang1, X Li, Q Huang, L Li, Y Chai, L Sun, X Wang, Y Zhu, Z Wang, Z Huang, Y Li, H Wu.   

Abstract

Waardenburg syndrome (WS) is characterized by sensorineural hearing loss and pigmentary defects of the hair, skin, and iris. Heterozygous mutations of MITF and its transactivator gene PAX3 are associated with Waardenburg syndrome type II (WS2) and type I (WS1), respectively. Most patients with MITF or PAX3 mutations, however, show variable penetrance of WS-associated phenotypes even within families segregating the same mutation, possibly mediated by genetic background or specific modifiers. In this study, we reported a rare Waardenburg syndrome simplex family in which a pair of WS parents gave birth to a child with double heterozygous mutations of MITF and PAX3. Compared to his parents who carried a single mutation in either MITF or PAX3, this child showed increased penetrance of pigmentary defects including white forelock, white eyebrows and eyelashes, and patchy facial depigmentation. This observation suggested that the expression level of MITF is closely correlated to the penetrance of WS, and variants in transcription regulator genes of MITF may modify the relevant clinical phenotypes.
© 2012 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22320238     DOI: 10.1111/j.1399-0004.2012.01853.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  8 in total

1.  A deletion in the Hermansky-Pudlak syndrome 4 (Hps4) gene appears to be responsible for albinism in channel catfish.

Authors:  Yueru Li; Xin Geng; Lisui Bao; Ahmed Elaswad; Kevin W Huggins; Rex Dunham; Zhanjiang Liu
Journal:  Mol Genet Genomics       Date:  2017-03-13       Impact factor: 3.291

Review 2.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Authors:  David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2013-07-03       Impact factor: 4.132

3.  A novel mutation of the MITF gene in a family with Waardenburg syndrome type 2: A case report.

Authors:  Yunfang Shi; Xiaozhou Li; Duan Ju; Yan Li; Xiuling Zhang; Ying Zhang
Journal:  Exp Ther Med       Date:  2016-02-01       Impact factor: 2.447

4.  Identification of a novel heterozygous mutation in the MITF gene in an Iranian family with Waardenburg syndrome type II using next-generation sequencing.

Authors:  Mahzad Nasirshalal; Mohammad Panahi; Nahid Javanshir; Hamzeh Salmani
Journal:  J Clin Lab Anal       Date:  2021-05-04       Impact factor: 2.352

5.  A Novel Frameshift Variant of the MITF Gene in a Chinese Family with Waardenburg Syndrome Type 2.

Authors:  Ying Li; Yajuan Xu; Genxia Li; Kang Chen; Haiyang Yu; Jinshuang Gao; Weifang Tian; Yuehua Liu; Pingping Liu; Linlin Zhang; Zhan Zhang
Journal:  Mol Syndromol       Date:  2021-06-14

6.  A follow-up study of a Chinese family with Waardenburg syndrome type II caused by a truncating mutation of MITF gene.

Authors:  Shuzhi Yang; Cuicui Wang; Chengyong Zhou; DongYang Kang; Xin Zhang; Huijun Yuan
Journal:  Mol Genet Genomic Med       Date:  2020-10-12       Impact factor: 2.183

7.  Molecular Etiology of Hereditary Single-Side Deafness: Its Association With Pigmentary Disorders and Waardenburg Syndrome.

Authors:  Shin Hye Kim; Ah Reum Kim; Hyun Seok Choi; Min Young Kim; Eun Hi Chun; Seung-Ha Oh; Byung Yoon Choi
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

8.  Molecular etiology and genotype-phenotype correlation of Chinese Han deaf patients with type I and type II Waardenburg Syndrome.

Authors:  Lianhua Sun; Xiaohua Li; Jun Shi; Xiuhong Pang; Yechen Hu; Xiaowen Wang; Hao Wu; Tao Yang
Journal:  Sci Rep       Date:  2016-10-19       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.